Pfizer Inc. “Fraudulent Marketing”: “Largest Health Care Fraud Settlement in Its History” (2009). US Department of Justice

Pfizer to Pay $2.3 Billion for Fraudulent Marketing

Introductory Note

This text originally published by the US Department of Justice in September 2009 is of utmost relevance in assessing the current actions of Big Pharma in promoting pharmaceutical products which are detrimental to people’s health.

Pfizer is currently involved in marketing its experimental mRNA vaccine. The FDA in an ambiguous statement has provided an Emergency Use Authorization (EUA) to the Pfizer-BioNTech COVID-19 Vaccine, while underscoring that the vaccine is “an unapproved product”.

Here is the precise text of the FDA issued on February 25, 2021:

The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product, Pfizer-BioNTech COVID-19 Vaccine, for active immunization to prevent COVID-19 in individuals 16 years of age and older. (emphasis added)

There is something “contradictory” in the FDA statement. The experimental Pfizer mRNA vaccine is “unapproved” by the FDA, yet it is “permitted”.

For further details see:

“Fraudulent Marketing”: The Pfizer COVID-19 Vaccine Is an “Unapproved Product” which Is “Permitted for Use”

By Prof Michel Chossudovsky, March 06, 2021

Below the text of the US Department of Justice 2009 Settlement with Pfizer, Inc.

Of relevance, the DoJ judgment required that Pfizer Inc. enter into a so-called “corporate integrity agreement” with the Office of the Inspector General of the DHHS.

The integrity agreement included procedures to ensure that Pfizer’s “conduct” would not happen again.